Evidence map›Paper›PMID 28339083›Full record

ReviewMolecular medicine reports2017

Health risk assessment of environmental selenium: Emerging evidence and challenges (Review).

Marco Vinceti, Tommaso Filippini, Silvia Cilloni, Annalisa Bargellini, Anna Valeria Vergoni, Aristides Tsatsakis, Margherita Ferrante

Abstract readReview
In one paragraph

Review in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Article
  4. Selenium deficiency-induced cardiomyopathy: a case report.European heart journal. Case reports · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marco VincetiCREAGEN, Research Center of Environmental, Genetic and Nutritional Epidemiology, Section of Public Health, University of Modena and Reggio Emilia, Modena, Italy.
Tommaso FilippiniCREAGEN, Research Center of Environmental, Genetic and Nutritional Epidemiology, Section of Public Health, University of Modena and Reggio Emilia, Modena, Italy.
Silvia CilloniCREAGEN, Research Center of Environmental, Genetic and Nutritional Epidemiology, Section of Public Health, University of Modena and Reggio Emilia, Modena, Italy.
Annalisa BargelliniCREAGEN, Research Center of Environmental, Genetic and Nutritional Epidemiology, Section of Public Health, University of Modena and Reggio Emilia, Modena, Italy.
Anna Valeria VergoniDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Aristides TsatsakisDepartment of Forensic Sciences and Toxicology, University of Crete, Heraklion, Crete, Greece.
Margherita FerranteDepartment of Medical, Surgical Sciences and Advanced Technologies 'G.F. Ingrassia', University of Catania, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New data have been accumulated in the scientific literature in recent years which allow a more adequate risk assessment of selenium with reference to human health. This new evidence comes from environmental studies, carried out in populations characterized by abnormally high or low selenium intakes, and from high-quality and large randomized controlled trials with selenium recently carried out in the US and in other countries. These trials have consistently shown no beneficial effect on cancer and cardiovascular risk, and have yielded indications of unexpected toxic effects of selenium exposure. Overall, these studies indicate that the minimal amount of environmental selenium which is source of risk to human health is much lower than anticipated on the basis of older studies, since toxic effects were shown at levels of intake as low as around 260 µg/day for organic selenium and around 16 µg/day for inorganic selenium. Conversely, populations with average selenium intake of less than 13-19 µg/day appear to be at risk of a severe cardiomyopathy, Keshan disease. Overall, there is the need to reconsider the selenium standards for dietary intake, drinking water, outdoor and indoor air levels, taking into account the recently discovered adverse health effects of low-dose selenium overexposure, and carefully assessing the significance of selenium-induced proteomic changes.

Indexed as

CardiomyopathiesClinical Trials as TopicDietary SupplementsEnterovirus InfectionsEnvironmental PollutantsHumansNeoplasmsOrganoselenium CompoundsRisk AssessmentSeleniumEnvironmental PollutantsOrganoselenium CompoundsSelenium

Identifiers

PMID28339083
PMCPMC5428396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.